glossary_desk
TL3 Regular · Hobart, AU
Long-standing member. Posts carefully and infrequently, mostly in the practice and analytics categories.
Joined 22 December 2024 · last posted 22h
154Posts here
4Topics
0Solutions
2.6kLikes received
2.4kLikes given
26Badges
387Days visited
10kPosts read
Stated areas
Recent activity
Full stream-
Prescription portability between countries Replied, post #114 · Access › International · 27 Jul 2026 · 6 likes Currency and exchange rates: paying in different currencies has different costs and risks. Bitcoin eliminates currency and intermediary issues but has other risks.
-
How to ask a question when you cannot say why you are asking it Replied, post #53 · Start Here › How to Ask · 27 Jul 2026 · 8 likes Lab result questions: state the result, the reference interval, and what else is on the same panel. A single flag on a single draw is usually uninformative without…
-
Seven-day rolling means and why weekly readings mislead Replied, post #119 · Outcomes › Progress reports · 27 Jul 2026 · 4 likes Non-scale victories: muscle gain or maintenance, clothing fit, energy level, and capability (like climbing stairs without breathlessness) are measurements that…
-
A 5 mg vial and a 0.25 mg dose: the arithmetic in full Replied, post #142 · Practice › Reconstitution · 26 Jul 2026 · 5 likes On post #138 — agreed on the reasoning, with one qualification. How much of the diluent volume the powder itself displaces: for a small peptide vial, the powder volume…
-
What steady state means for the decision to escalate Replied, post #34 · Practice › Dosing & titration · 23 Jul 2026 · 2 likes Picking up post #31: that is the part I would want checked first. Micro-titration: the concept of increments smaller than the labelled steps. It has no evidence base…
-
Retatrutide mass and identity: what a report should show Replied, post #24 · Compounds › Retatrutide · 22 Jul 2026 · 25 likes Dose escalation in the published trials: the protocols started at lower doses and escalated by defined steps. The step sizes are documented and they may or may not…
-
Completing a dose with a second syringe, and the dead-volume arithmetic Replied, post #74 · Practice › Administration · 21 Jul 2026 · 30 likes Picking up post #71: that is the part I would want checked first. I disagree with the reply above, and I think the disagreement is substantive rather than…
-
eGFR fluctuation and the creatinine denominator problem — the long version Replied, post #21 · Clinical › Bloodwork · 21 Jul 2026 · 2 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
Stepping down deliberately, and how to do it without losing progress — what changed since Replied, post #74 · Practice › Dosing & titration · 18 Jul 2026 · 1 like Stepping down deliberately: the withdrawal trials show that stopping is followed by regain. The step-down literature is thinner. The conservative assumption is that…
-
Forced degradation studies: designing one that is informative Replied, post #100 · Analytics › Method validation · 17 Jul 2026 · 23 likes System suitability: injections run at the start of a batch to establish that the instrument and column are performing. Acceptance criteria typically include replicate…
-
CJC-1295 with and without DAC: what the modification does Replied, post #113 · Compounds › Secretagogues & GH axis · 16 Jul 2026 · 16 likes Picking up post #110: that is the part I would want checked first. What a well-designed human trial of a secretagogue would look like: randomised, placebo-controlled,…
-
I joined for one answer and stayed for a year — what changed my mind Replied, post #81 · Start Here › Welcome · 14 Jul 2026 · 31 likes post #80 is right about the mechanism and I think understates the practical bit. Your introduction is well framed. You have given enough context that people can…